SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001367644-17-000014
Filing Date
2017-02-28
Accepted
2017-02-27 20:38:31
Documents
80
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm 10-K 2155892
2 exhibit10-5.htm EX-10.5 45410
3 exhibit10-6.htm EX-10.6 45284
4 exhibit10-24.htm EX-10.24 397735
5 exhibit12.htm EX-12.1 49412
6 exhibit21.htm EX-21 11907
7 exhibit23.htm EX-23.1 7916
8 exhibit31-1.htm EX-31.1 12662
9 exhibit31-2.htm EX-31.2 12627
10 exhibit32-1.htm EX-32.1 4574
11 exhibit32-2.htm EX-32.2 4552
  Complete submission text file 0001367644-17-000014.txt   10458319

Data Files

Seq Description Document Type Size
12 XBRL INSTANCE DOCUMENT ebs-20161231.xml EX-101.INS 1954662
13 XBRL TAXONOMY EXTENSION SCHEMA ebs-20161231.xsd EX-101.SCH 61978
14 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ebs-20161231_cal.xml EX-101.CAL 122656
15 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ebs-20161231_def.xml EX-101.DEF 355420
16 XBRL TAXONOMY EXTENSION LABEL LINKBASE ebs-20161231_lab.xml EX-101.LAB 1079702
17 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ebs-20161231_pre.xml EX-101.PRE 615829
Mailing Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879
Business Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879 240-631-3200
Emergent BioSolutions Inc. (Filer) CIK: 0001367644 (see all company filings)

IRS No.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-33137 | Film No.: 17644370
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences